Considerations on Lipid Management Strategies for Patients Aged 75 Years and Older with Atherosclerotic Cardiovascular Disease
Abstract：Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and disability in the elderly, with its prevalence and mortality increasing with age. Dyslipidemia is an independent risk factor for ASCVD and cardiovascular events. Extensive evidence shows that statin drugs can delay the occurrence and progression of ASCVD in the elderly and reduce the risk of cardiovascular events and mortality. However, due to concerns about the safety of statins, there are issues of under-dosing and high discontinuation rates among the elderly population.
Keywords：Cardiovascular diseaseCholesterolLDLAtherosclerosisLipid management strategy
Publication Date：2025-07-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 833-835 )